Preoperative Prehabilitation Program For Geriatric Patients in a Rural Healthcare Setting

NCT06518369 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2025-06-08

No results posted yet for this study

Summary

The study will include patients who require elective major abdominal surgery for cancerous or non-cancerous conditions. The goal of the research is to assess the benefit of a prehabilitation program before surgery that includes nutrition, exercise, smoking cessation, and optimization of chronic disease. A group of 10 patients will take part in a prehabilitation program. These patients will be compared to 20 patients who received standard of care.

Conditions

  • Surgery

Interventions

OTHER

Prehabilitation

Prehabilitation program for 4-6 weeks before surgery will include: * Review of the frailty risk analysis calculator score obtained in the frailty study (#2212-74) * Review of lab results including complete blood count, creatinine, albumin, and prealbumin * Review of chronic conditions. * An office visit or telehealth visit to review instructions on instructions on nutrition, exercise, smoking cessation, and optimization of chronic disease. * Drinking surgery immunonutrition drinks twice daily for 5 days before surgery. * Educational information and video instruction * Weekly phone calls to motivate, ensure adherence, and assess progress. * Measurements of hand grip strength and body weight

Sponsors & Collaborators

  • The Guthrie Clinic

    lead OTHER

Principal Investigators

  • Nancy Georgetson, AGNP-C · Robert Packer Hospital Sayre PA

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-18
Primary Completion
2024-10-16
Completion
2025-06-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06518369 on ClinicalTrials.gov